Furthermore, CAR-NK-cell function may be improved by rational drug combination strategies such as epigenetic modulators, oncolytic viruses, small molecule inhibitors, [63] or with stimulator of interferon genes (STING) agonists which have recently been demonstrated to potentiate CAR-NK-cell killing of tumour cells [81, 82]. The gene discussed is STING1; the disease is neoplasm.